Monarch Medical Technologies
Brian Duffy is the President of Monarch Medical Technologies and an Executive Board Member at the same company. Brian is also a Partner at Eigen Capital, where Brian specializes in M&A investing in the Mid Market. Previously, Brian was the Owner of B. Gordon Financial Consulting, offering M&A advisory services for PE Firms and High Net Worth individuals. Prior to that, Brian held the position of Senior Vice President at Platinum Equity and Wells Fargo Foothill. Brian completed their education at Providence College in 1993.
This person is not in the org chart
Monarch Medical Technologies
Monarch Medical Technologies is a digital health company committed to helping hospitals and health systems deliver optimal glycemic management for critical care and non-critical care patients alike. Insulin dosing has always been a daunting and time-intensive task, but now that burnout and staffing constraints have reached record highs, never have the associated risks and challenges been more acute. Add the impacts of new CMS measures for hyperglycemia and hypoglycemia, and you have the perfect storm. Our FDA-cleared EndoTool® Glucose Management System is designed specifically to displace traditional manual methods of insulin dosing with an intuitive and easy-to-use software application that integrates seamlessly with your EMR. This pioneering clinical decision support platform offers both intravenous and subcutaneous modalities, and has been shown to safely and reliably achieve and maintain target glucose goals. Specialized features help clinicians address the complexities of treating patients with diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic nonketotic syndrome (HHS), gestational diabetes, impaired kidney function, residual insulin, and presence of steroids.